#U.S. Population Health Management Market Growth Forecast

[market-insider]

COVID-19 Pandemic Changed The Outlook Of U.S. Population Health Management Market

The U.S. population health management market size is expected to reach USD 103.7 billion in 2030, registering a CAGR of 19.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increase in healthcare expenditure, need for value-based healthcare delivery, and effective disease management across different care settings are among the key factors expected to drive the market during the forecast period.

In the U.S., poor healthcare management results in the loss of productivity and a significant portion of healthcare costs. Adoption of PHM software by employers helps in the management of their healthcare budget as they can keep a track of the employees’ health status. The market is likely to witness rapid growth in the coming years due to the growing demand for healthcare IT services and solutions that encourage healthcare delivery reliant on value, resulting in a transition from Fee-For-Service to a value-based payment model.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Population Health Management Market Report

Population health management is built on a Fee-for-Service (FFS) reimbursement method, wherein physicians and other healthcare providers are reimbursed by government agencies and insurance companies on basis of the number of services offered to patients. The new payment model allows reimbursement based on the quality of care delivered and provides comprehensive tools to handle financial and clinical risk for value-based care delivery.

The COVID-19 pandemic has changed the outlook of healthcare in the U.S. with the advanced use of web-based technology in healthcare. Healthcare providers are increasingly investing in PHM software to offer better outcomes. PHM can also be used for tracking the vital signs of patients discharged from hospitals, which can then be analyzed to offer meaningful insights into a patient’s health. The lockdown has disrupted the existing system and PHM systems are the current need to manage the patient population.

[healthcaremarketfmi]

Medical Disposables Market to be worth US$ 326 Billion by 2033, Reveals Future Market Insights

The Medical Disposables Market revenues were estimated at US$ 153.5 Billion in 2022 and is anticipated to grow at a CAGR of 7.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 326 Billion. Bandages and Wound Dressings commanded the largest revenue share in 2022 and is expected to register a CAGR of 6.8% from 2023 to 2033.

The rising incidence of Hospital Acquired Infections, an increasing number of surgical procedures, and the growing prevalence of chronic diseases leading to longer hospital admission have been the key factors driving the market.

The subsequent spike in the number of chronic illness cases and a rise in the rate of hospitalizations has fueled the field of emergency medical disposables growth. The expansion of the medical disposables market is being fueled by an increase in the prevalence of hospital-acquired illnesses and disorders, as well as a greater focus on infection prevention. For example, the prevalence of healthcare-associated infection in high-income countries ranges from 3.5% to 12%, whereas it ranges from 5.7% to 19.1% in low and medium-income countries.

A growing geriatric population, an increase in the incidence of incontinence issues, mandatory guidelines that must be followed for patient safety at healthcare institutions, and an increase in demand for sophisticated healthcare facilities is driving the medical disposables market.

The market in North America is expected to reach a valuation of US$ 131 Billion by 2033 from US$ 61.7 Billion in 2022. In August 2000, the Food and Drug Administration (FDA) issued guidance concerning healthcare single-use items reprocessed by third parties or hospitals. In this guidance, FDA stated that hospitals or third-party reprocessors would be considered manufacturers and regulated in the exact same manner. A newly used single-use device still has to fulfill the criteria for device activation required by its flagship when it was originally manufactured. Such regulations have been creating a positive impact on the medical disposables market in the U.S. market in specific and the North American market in general

Competitive Landscape

The key companies in the market are engaged in mergers, acquisitions and partnerships.

The key players in the market include 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health.

Some of the recent developments of key Medical Disposables providers are as follows:

In April 2019, Smith & Nephew PLC purchased Osiris Therapeutics, Inc. with the goal of expanding its advanced wound management product range.

In May 2019, 3M announced the acquisition of Acelity Inc., with the goal of strengthening wound treatment products.

For More Information: https://www.futuremarketinsights.com/reports/medication-dispenser-market

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Medical Disposables Market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.

The study reveals essential insights by Product (Surgical Instruments & Supplies, Infusion, and Hypodermic Devices, Diagnostic & Laboratory Disposables, Bandages and Would Dressings, Sterilization Supplies, Respiratory Devices, Dialysis Disposables, Medical & Laboratory Gloves), by Raw Material (Plastic Resin, Nonwoven Material, Rubber, Metal, Glass, Others), by End-use (Hospitals, Home Healthcare, Outpatient/Primary Care Facilities, Other End-use) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Market Segments Covered in Medical Disposables Industry Analysis

By Product Type:

Surgical Instruments & Supplies

Would Closures

Procedural Kits & Trays

Surgical Catheters

Surgical Instruments

Plastic Surgical Drapes

By Raw Material:

Plastic Resin

Nonwoven Material

Rubber

Metals

Glass

Other Raw Materials

By End-use:

Hospitals

Home Healthcare

Outpatient/Primary Care Facilities

Other End-uses

[techsciresearch]

United States Solid Waste Management Vehicle Market Size, Growth & Trends 2026

Surge in demand of robotic Solid Waste Management Vehicle in the country is driving the growth of United States Solid Waste Management Vehicle Market, in the forecast period.

United States solid waste management vehicle market are anticipated to show a robust growth in the upcoming five years, 2022-2027. The market growth can be attributed to the rising demand of management of solid waste generated in the country. Moreover, the government funded awareness drives and schemes have created enough concerns among the general population about the rapidly degrading environmental health. The concerns are driving the surge in the demand of vehicles that can easily and comfortably transport the waste from each nook and corner of the country to the degradation sites where proper waste management process can be carried out. Daily generation of the solid waste is too high in the country. According to EPA, a common American in a day can produce about 5.5 to 6 pounds of trash. Environmental Protection Agency of United States (US EPA) is the governing body that handles and regulates the solid waste management in all the states. EPA promotes and encourages the processes of solid waste management by source reduction, recycling, composting, landfills, energy recovery from waste, and managing the transfer stations.

According to TechSci report on, “United States Solid Waste Management Vehicle Market By Vehicle Type (Auto Tipper or Hopper Tipper, Garbage Compactor Truck, Dumper Placer, Earth Moving Equipment) By Region, Competition Forecast & Opportunities, 2026”, United States solid waste management vehicle market is anticipated to show a robust growth in the forecast period 2022-2026 with an impressive CAGR on the account of rising demand of better and convenient transportation system of the solid waste management as well as the surge in the demand of the better management of the solid waste that is being produced daily in the country. Moreover, exponential rate of expansion of industrial activities and inappropriate methods of waste management are expected to boost the growth of the United States solid waste management vehicle market in the next five years. Due to rapid population growth and urbanization, the solid waste production has increased therefore authorities have been making stricter rules and regulations regarding the solid waste management and industrial wastes, the process involves a major category of vehicles that transports the garbage from door to door and transports it to the solid waste management factories, which is driving the growth of the United States solid waste management vehicles market in the next five years.

According to the U.S. classification of trucks (class 1 to class 9), refuse collection trucks fall under the class 8 category, which is considered a category for heavy trucks. In the U.S., while heavy trucks contribute merely 4% of total vehicles, they are estimated to be responsible for ~30% of vehicle emission and ~26% of fuel usage. Also, demand of electric and hybrid electric vehicles that may help in the solid waste management is increasing. Mostly for the heavy duty trucks which contributes to the hazardous fuel emission. The electric and hybrid vehicles would have great impact on the emissions with their cleaner economics and outsized impact. Thus, the factor is also inclusive in the list of driving factors of the United States solid waste management vehicle market growth in the upcoming five years.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "United States Solid Waste Management Vehicle Market"

https://www.techsciresearch.com/report/united-states-solid-waste-management-vehicle-market/7506.html

The United States solid waste management vehicle market is segmented by vehicle type, regional distribution and competitional landscape. Based on vehicle type, the market is further bifurcated into auto tipper or hopper tipper, garbage compactor truck, dumper placer, and earth moving equipment. Auto tipper or hopper tipper are anticipated to hold the largest shares of the market and assert its dominance over other type of the solid waste management vehicle market on grounds of the surge in the demand and requirement to collect the garbage from door to door. Auto tippers are a refuse compactor vehicle, that is mounted with solid waste collection equipment. It is often designed for lifting and unloading the garbage from bins, and small collectors. Garbage compactor trucks are a kind of portable compactors. A compactor body is mounted on a truck along with a container. It is designed to be transported by specially designed Hook Loader Unit, which is driven to the dumping ground/processing plant for discharge of compacted garbage. Dumper placer is a truck that is mounted with hydraulically operated arms and lifting mechanism that collects, lifts, transports, tips, etc.

Holding the largest revenue of the market shares, a partial list of the market players includes Waste Management Inc., Republic Services Inc., Waste Connection Inc., Clean Harbors Inc., Covanta Holding Corporation, US Ecology, Inc, Oshkosh Corporation, Dover corporation, New Way manufacturers, Amalgamations Repco Ltd, among others. The market players are actively involved in the development of the technologically advanced composter vehicles such that the transportation and the solid waste management cost can be reduced. Since the government has acute responsibility in the sector, the venturing capital and other financial sustenance is not an issue and supports the further growth of the market in the upcoming five years.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7506

Customers can also request for 10% free customization on this report.

“Solid waste management vehicles with the technological advancements are capable to automatically lift, and tip over the garbage containers to collect the garbage. More advancements may include features like recycling of garbage and separating the non-recyclable from the recyclable waste. Market players must attenuate themselves with the government policies and governmental norms for the future settlement of the market. Since the waste management companies often have their own trucks and compost vehicles; solid waste management vehicle manufactures must collaborate with the management companies and supply the demands,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Press release : https://www.techsciresearch.com/news/5963-united-states-solid-waste-management-vehicle-market-to-grow-with-an-impressive-cagr-until-2026.html

“United States Solid Waste Management Vehicle Market By Vehicle Type (Auto Tipper or Hopper Tipper, Garbage Compactor Truck, Dumper Placer, Earth Moving Equipment) By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of United States solid waste management vehicle market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States solid waste management vehicle market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Web:   https://www.techsciresearch.com/

[newsmarketreports]

Global Life Insurance Market Analysis: Trends, Growth, and Future Outlook

The life insurance market plays a critical role in global financial stability and individual financial planning. As economies grow and populations evolve, life insurance has become a key instrument for wealth management, risk mitigation, and legacy planning. This article explores the current state of the global life insurance market, key trends, growth drivers, and the future outlook.

Buy Full Report to Gain More Information about the Life Insurance Market Forecast

Download A Free Report Sample

Key Market Drivers

1. Increasing Awareness of Financial Planning

With rising awareness about financial security and the importance of planning for unforeseen circumstances, more individuals and families are investing in life insurance. Life insurance policies are no longer limited to death benefits; they now encompass a variety of financial products such as term insurance, whole life insurance, and endowment policies.

The increasing need for financial protection and risk management is a primary driver of market growth.

2. Aging Global Population

The aging population is a major factor contributing to the expansion of the life insurance market. Countries with higher life expectancy rates, particularly in Europe, Japan, and the United States, are witnessing significant demand for insurance products tailored to senior citizens, including policies that cover healthcare costs, long-term care, and estate planning.

As the global population over the age of 60 continues to grow, there will be increased demand for life insurance products designed to provide financial support in later years.

3. Technological Advancements and Digital Platforms

Digital transformation in the insurance sector has streamlined processes such as underwriting, policy management, and claims processing. Insurers are leveraging big data, artificial intelligence (AI), and machine learning to assess risk more accurately and offer personalized policies. These advancements also make insurance more accessible to a wider range of consumers through mobile apps and online platforms.

Technology is driving efficiency and improving customer engagement, thus accelerating the market’s growth trajectory.

Market Trends

1. Growing Popularity of Term Life Insurance

Term life insurance has emerged as one of the most sought-after insurance products due to its affordability and flexibility. Unlike whole life policies, term insurance provides coverage for a specific period, making it more cost-effective for young policyholders and families seeking temporary financial protection.

The increasing preference for short-term protection solutions aligns with the economic priorities of younger generations.

2. The Rise of Unit-Linked Insurance Plans (ULIPs)

Unit-Linked Insurance Plans (ULIPs) combine life insurance coverage with investment opportunities, appealing to customers looking for both risk coverage and wealth creation. With market-linked returns and flexible premium payment options, ULIPs are gaining popularity in regions such as Asia and the Middle East.

Consumers now prefer investment-driven life insurance products, where they can actively participate in the growth of their portfolios.

3. Focus on Health and Wellness-Linked Policies

In the wake of the COVID-19 pandemic, consumers are increasingly seeking insurance products that provide health coverage alongside traditional life insurance benefits. Many insurers are now offering life policies that incorporate wellness programs, incentivizing healthy lifestyles and preventive care through premium discounts.

The integration of health incentives within life insurance policies reflects the growing importance of holistic well-being.

Regional Analysis

1. North America

North America remains one of the largest markets for life insurance, driven by high disposable income levels and a well-established insurance industry. The U.S., in particular, leads the region with innovative product offerings and strong market competition among life insurers.

The region is characterized by a demand for diverse life insurance products, from whole life insurance to variable universal life policies.

2. Europe

Europe's life insurance market is experiencing moderate growth, with countries such as Germany, France, and the UK showing robust demand for life and pension-related insurance products. The aging population and government initiatives to promote financial planning are key contributors to the market’s stability.

With stringent regulatory frameworks and an emphasis on consumer protection, Europe remains a highly regulated but lucrative market for insurers.

3. Asia-Pacific

The Asia-Pacific region is seeing rapid growth in life insurance adoption, with emerging economies like China, India, and Indonesia leading the way. The rising middle class, increasing financial literacy, and government-led initiatives to promote life insurance are major drivers of market expansion in this region.

In China, for example, life insurance premiums are growing due to government support and a burgeoning population seeking financial protection.

4. Latin America and the Middle East

The life insurance market in Latin America and the Middle East is still developing, but shows significant growth potential. In countries such as Brazil, Mexico, and Saudi Arabia, the rising awareness of the need for financial protection and increasing disposable income are helping to drive demand for life insurance products.

Challenges Facing the Market

1. Regulatory and Compliance Challenges

The life insurance market is subject to strict regulatory requirements that vary from country to country. Insurers must navigate a complex landscape of legal frameworks, tax structures, and compliance obligations, which can hinder rapid market expansion.

In regions like Europe, life insurers are faced with stringent requirements under directives such as Solvency II, adding to operational complexities.

2. Economic Instability

Economic fluctuations and recessions can impact consumer confidence and purchasing power, leading to a slowdown in life insurance policy sales. In particular, periods of high inflation can affect the affordability of life insurance premiums, especially in emerging markets.

Insurers need to adapt to economic cycles and offer more flexible payment options to stay competitive.

3. Rising Competition

As the life insurance market becomes more crowded with both traditional insurers and insurtech startups, competition is intensifying. New entrants are focusing on digital solutions, offering tailored policies at lower costs. To remain competitive, established life insurance companies must continue to innovate and enhance their digital presence.

Future Outlook

The global life insurance market is expected to witness continued growth, driven by increasing consumer awareness, technological advancements, and the development of new life insurance products. Key innovations in telematics, wearable technology, and data-driven underwriting processes will further revolutionize the industry.

Sustainability in Life Insurance

A growing trend toward sustainable finance is emerging within the insurance sector. Companies are starting to align their policies with Environmental, Social, and Governance (ESG) criteria, which appeal to consumers who prioritize ethical investments. As such, life insurers will increasingly adopt sustainable practices to attract these conscientious consumers.

Conclusion

The global life insurance market is evolving rapidly, adapting to technological changes, shifting consumer preferences, and emerging economic trends. By leveraging digital innovation and expanding into new markets, life insurance companies can continue to thrive in an increasingly competitive landscape.

[shubhampawrainfinium]

Viscosupplementation in Focus: The Latest Advances in Joint Lubrication

The global viscosupplementation market is on a growth trajectory, driven by increasing awareness of joint health and advancements in treatment options. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of nearly 7% over the forecast period of 2022-2028. With a revenue of over USD 3 billion in 2022, the market is expected to reach approximately USD 5 billion by 2028.

What is Viscosupplementation?

Viscosupplementation involves the injection of hyaluronic acid (HA) or other viscoelastic substances into the joint space to alleviate pain and improve joint function. This treatment is commonly used for managing osteoarthritis (OA) and other joint-related conditions. The injected material helps to lubricate the joint, reduce friction, and provide cushioning, leading to pain relief and improved mobility.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/887

Market Dynamics and Growth Drivers

Several factors are contributing to the growth of the global viscosupplementation market:

Rising Prevalence of Osteoarthritis: The increasing incidence of osteoarthritis, particularly among the aging population, is driving the demand for viscosupplementation treatments. OA is a leading cause of joint pain and disability, and viscosupplementation provides an effective option for managing symptoms.

Advancements in Technology: Technological advancements in viscosupplementation products, including the development of new formulations and delivery systems, are enhancing the effectiveness and safety of treatments. Innovations in hyaluronic acid formulations and injection techniques are contributing to market growth.

Growing Awareness and Acceptance: There is increasing awareness among patients and healthcare providers about the benefits of viscosupplementation for joint health. As more people become aware of this treatment option, the demand for viscosupplementation is expected to rise.

Increasing Number of Orthopedic Procedures: The rising number of orthopedic procedures, including joint injections and minimally invasive surgeries, is driving the demand for viscosupplementation products. Healthcare providers are increasingly incorporating viscosupplementation into treatment plans for managing joint conditions.

Supportive Reimbursement Policies: Favorable reimbursement policies and coverage for viscosupplementation treatments are encouraging patients to seek these therapies. Insurance coverage and reimbursement support contribute to the accessibility and affordability of viscosupplementation.

Regional Analysis

North America: North America is a leading market for viscosupplementation, driven by the high prevalence of osteoarthritis, advanced healthcare infrastructure, and strong demand for joint health solutions. The U.S. and Canada are key markets, with significant adoption of viscosupplementation treatments.

Europe: Europe is experiencing steady growth in the viscosupplementation market, supported by increasing awareness of joint health and advancements in treatment options. Countries such as Germany, France, and the U.K. are prominent markets, with growing adoption of viscosupplementation therapies.

Asia-Pacific: The Asia-Pacific region is witnessing rapid growth in the viscosupplementation market, driven by rising healthcare expenditures and increasing prevalence of joint disorders. Emerging economies in the region, such as China and India, are contributing to market expansion.

Latin America and Middle East & Africa: These regions are also experiencing growth in the viscosupplementation market, influenced by increasing healthcare infrastructure and rising awareness of joint health. Market expansion is supported by growing healthcare investments and improving access to treatments.

Competitive Landscape

The viscosupplementation market is competitive, with several key players and emerging companies offering a range of products. Notable players in the market include:

Allergan plc: A leading provider of viscosupplementation products, known for its Juvederm® range of hyaluronic acid-based injectables.

Medytox Inc.: Offers a range of viscosupplementation products, including hyaluronic acid-based solutions for joint health.

Revance Therapeutics, Inc.: Specializes in viscosupplementation treatments and innovative hyaluronic acid formulations.

Smith & Nephew plc: Provides viscosupplementation products for joint health and orthopedic applications.

Hylan Bio Inc.: Known for its hyaluronic acid-based viscosupplementation products for managing joint pain.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-viscosupplementation-market

Challenges and Opportunities

The viscosupplementation market faces challenges such as the high cost of treatment and the need for periodic injections, which may affect patient compliance. Additionally, there may be variability in the efficacy of viscosupplementation products and the potential for adverse effects.

However, there are significant opportunities for growth. Increasing adoption of minimally invasive procedures, advancements in product formulations, and supportive reimbursement policies present avenues for market expansion. Companies that focus on innovation, cost reduction, and improving patient outcomes are well-positioned to capitalize on the growing demand for viscosupplementation treatments.

Conclusion

The global viscosupplementation market is poised for substantial growth, driven by rising prevalence of osteoarthritis, technological advancements, and increasing awareness of joint health. With revenue expected to reach approximately USD 5 billion by 2028, the market presents significant opportunities for investment and innovation. As the demand for effective joint health solutions continues to rise, viscosupplementation will play a crucial role in enhancing quality of life for individuals with joint conditions.

[health-views-updates]

2024 Compounding Pharmacies Market Dynamics: Trends and Insights

The global compounding pharmacies market is projected to witness steady growth over the next decade, with its market size expected to increase from USD 12.6 billion in 2023 to USD 19.9 billion by 2032. The market will experience a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2024 to 2032, driven by rising demand for personalized medications and tailored healthcare solutions.

Compounding pharmacies provide customized medications by combining, altering, or mixing ingredients to meet individual patient needs. These pharmacies are particularly beneficial for patients who require specific doses, alternative forms of medication, or allergen-free formulations that are not available in mass-produced pharmaceutical products. As the healthcare landscape shifts toward more personalized approaches, the compounding pharmacy industry is poised for consistent growth.

Get Free Sample PDF: https://www.snsinsider.com/sample-request/4513 

Key Market Drivers

Rising Demand for Personalized Medication: One of the primary growth drivers for the compounding pharmacies market is the increasing demand for personalized healthcare. Standard pharmaceutical products do not always meet the specific needs of every patient. Compounding pharmacies play a crucial role in filling this gap by offering custom formulations that cater to individual patient requirements, such as adjusting medication strengths, flavors, or delivery methods. This trend is especially prevalent in treating chronic conditions, hormone replacement therapies, and pediatric care.

Growth of Geriatric Population: The global aging population is a significant factor contributing to the expansion of the compounding pharmacies market. Older adults often require personalized medication solutions due to polypharmacy (the use of multiple medications) and the need for tailored dosages. Many elderly patients also face difficulties in swallowing pills, leading to a demand for liquid formulations or transdermal options that compounding pharmacies can provide.

Increasing Incidence of Chronic Diseases: The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer has further propelled the need for customized therapies. Compounding pharmacies are able to develop medications that are tailored to manage the symptoms of these conditions effectively. In addition, they can create formulations that address medication shortages or provide alternative treatments when commercial drugs are unavailable.

Regulatory Support and Innovations: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) are increasingly supporting the use of compounding pharmacies, provided they adhere to stringent quality standards. Regulatory initiatives, along with technological advancements in compounding techniques, are creating new opportunities for market growth. Innovations in drug delivery methods, automation, and formulation technologies are further enhancing the capabilities of compounding pharmacies to produce high-quality and safe medications.

Challenges and Market Opportunities

Despite the positive outlook, the compounding pharmacies market faces several challenges. Stringent regulatory frameworks and concerns over the safety and efficacy of compounded medications can hinder market growth. Compounding pharmacies must meet rigorous quality standards, and any lapses can affect public trust and demand for their services.

However, the increasing focus on patient-centric care, coupled with technological advancements in drug compounding, presents ample opportunities. Automation in compounding processes is reducing the risk of human error, while digital health solutions are making it easier for healthcare providers to prescribe customized medications. Additionally, the market is expected to see growth in veterinary compounding, as pet owners seek personalized treatments for their animals.

Regional Insights

North America remains the largest market for compounding pharmacies, driven by the presence of advanced healthcare infrastructure and a strong focus on personalized medicine. The United States, in particular, has a well-established regulatory framework that supports compounding pharmacies, leading to the proliferation of these services.

Europe is also witnessing steady growth, especially in countries like Germany, the UK, and France, where there is increasing awareness of the benefits of personalized medication. Meanwhile, the Asia-Pacific region is emerging as a key growth area due to its expanding healthcare sector, growing patient population, and increasing demand for customized treatments.

Future Outlook

The future of the compounding pharmacies market looks promising, as healthcare continues to move toward a more personalized and patient-centric model. With a projected CAGR of 5.2% from 2024 to 2032, the market is expected to see innovations in compounding technologies and broader adoption of custom medications across various therapeutic areas.

In conclusion, the global compounding pharmacies market, valued at USD 12.6 billion in 2023, is on track to reach USD 19.9 billion by 2032. With the rising demand for personalized medicine, the growth of the aging population, and advancements in compounding techniques, this market is set for significant expansion over the next decade.

Other Trending Reports

Dental Suction Systems Market

Cosmeceuticals Market

Cell Therapy Market

Growth Hormone Deficiency Market

[ankitab]

Meticulous Research®: Global Alzheimer’s Drugs Market - Trends, Innovations, and Future Forecast

The Alzheimer’s Drugs Market is projected to reach $9.62 billion by 2031, growing at a CAGR of 9.8% from 2024 to 2031. The market growth is driven by the increasing global burden of Alzheimer's disease, rising prevalence of risk factors, surge in research funding, introduction of innovative technologies, increasing number of approvals, and a growing pipeline of clinical trials and products. Additional growth opportunities are expected from expanding research activities in developing countries, heightened awareness programs, public and private initiatives, combination drug therapies, and advanced biomarkers and imaging techniques for diagnosis and management.

Free Download sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5947?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

Key Market Growth Drivers

Increasing Burden of Alzheimer’s Disease

Alzheimer’s disease, the most common type of dementia, causes a progressive decline in memory, organizing, learning, and thinking skills. The prevalence of neurodegenerative disorders like Alzheimer's is increasing due to aging populations, traumatic brain injuries, genetic factors, stress, and other lifestyle risk factors. According to the Alzheimer's Association (U.S.), the prevalence of Alzheimer’s disease among those aged 65 and older is projected to rise from 6.2 million in 2021 to 6.9 million in 2024. This growing prevalence is expected to drive demand for Alzheimer’s drugs.

Increase in Research Funding

With the increasing prevalence of Alzheimer’s disease, there is a rising need for novel therapies. Both public and private entities are significantly funding research to understand the disease better and develop effective treatments. For instance, Alzheimer’s and dementia research funding at the National Institutes of Health (NIH) increased from USD 2.8 billion in 2021 to USD 3.8 billion in 2023. Key recent funding highlights include:

May 2024: NeuroTherapia received a grant from the Alzheimer's Association to develop its NTRX-07 drug for Alzheimer's treatment.

October 2023: The National Institute on Aging awarded USD 151 million to the University of California San Francisco for a clinical trial combining anti-amyloid and tau therapies.

Emerging Market Trends

Stem Cell Therapy

Stem cell therapy is a promising treatment for Alzheimer’s disease, reducing amyloid β-protein deposition and alleviating memory loss symptoms. The first stem cell therapy for Alzheimer’s was approved in Japan in 2018, leading to increased research and clinical trials in this field.

Telehealth in Alzheimer’s Care

Telehealth offers a cost-effective and convenient alternative to traditional long-term residential care for Alzheimer's patients. It provides services such as consultations, medication management, and follow-up appointments via video conferencing. Telehealth improves patient adherence to treatment regimens, thereby managing symptoms more effectively and driving market growth.

Browse in depth: https://www.meticulousresearch.com/product/alzheimers-drugs-market-5947?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

Market Opportunities

Combination Therapy

Combination therapy, using two therapeutic agents together, shows promise in treating Alzheimer’s disease. For instance, combining memantine with cholinesterase inhibitors has demonstrated higher efficacy in clinical trials compared to monotherapy. This approach targets multiple pathways involved in Alzheimer’s, offering potential benefits to patients.

Market Segmentation Analysis

By Drug Type

Cholinesterase Inhibitors: Expected to dominate with a 46.9% market share in 2024 due to their effectiveness in treating mild to moderate Alzheimer’s by decreasing acetylcholine breakdown.

NMDA Receptor Antagonists

Glutamate Regulators

Combination Drugs

By Application

Symptom Management: Predicted to account for 87.2% of the market in 2024. Symptom management drugs slow disease progression, reduce healthcare costs, and address symptoms like impaired judgment and memory loss, increasing their demand.

Geographical Analysis

North America

North America is expected to hold the largest market share (43.0%) in 2024, driven by the high prevalence of Alzheimer’s, substantial research funding, the presence of key players, numerous clinical trials, and favorable reimbursement policies. For instance, in February 2024, the Centers for Medicare & Medicaid Services covered Leqembi (Lecanemab), a recently approved Alzheimer’s medication.

Asia-Pacific

Asia-Pacific is anticipated to register the highest growth rate (11.4%) during the forecast period, with significant opportunities in China, India, and South Korea. Factors include a growing pharmaceutical industry, supportive government initiatives, and extensive clinical trials. For example, Bredis Healthcare received USD 1.27 million from the South Korean Ministry of SMEs and Startups in August 2023 for developing diagnostic tests for Alzheimer’s.

Quick buy: https://www.meticulousresearch.com/Checkout/23211142?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

Leading Companies

Key players in the Alzheimer’s drugs market include Biogen, Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Eisai Co., Ltd., SUPERNUS PHARMACEUTICALS, INC., H. Lundbeck A/S, AC Immune SA, Zydus Lifesciences Limited, Johnson & Johnson, and Daiichi Sankyo Company. These companies are recognized for their extensive product portfolios, strategic geographical presence, and robust growth strategies from 2020 to 2024.

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[kathansky]

Global Animal Health Market: Size, Share, Growth, Industry Trends | 2024-2031

Leading market research firm SkyQuest Technology Group recently released a study titled 'Animal Health Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Animal Health report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Animal Health Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

The research analysis on the global Animal Health Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Animal Health Market circumstances in the forecast period between 2024 and 2031. The global Animal Health Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Animal Health Market has experienced robust growth over the past decade and is projected to continue expanding. Global Animal Health Market size was valued at USD 58.28 billion in 2022 and is poised to grow from USD 63 billion in 2023 to USD 117.48 billion by 2031, at a CAGR of 8.1% over the forecast period (2024- 2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

Chance to get a free sample @ https://www.skyquestt.com/sample-request/animal-health-market 

Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Animal Health Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

Animal Type

Production Animals (Poultry, Swine, Cattle, Sheep & Goats, Fish), Companion Animal (Dog, Cat, Horse, Others)

Product

Biologics (Vaccines [Modified/ Attenuated Live,Inactivated(Killed), Other Vaccines], Other Biologics), Pharmaceuticals (Parasiticides, Anti-Infectives, Anti -Inflammatory, Analgesics, other), Medicinal Feed Additives, Diagnostics (Consumables, Reagents and Kits,Instruments and Devices), Equipment & Disposables (Critical care Consumables, Anesthesia equipment, Temprature Management Equipment, Rescue & Resuscitation Equipment, Research Equipment, Patient Monitoring Equipment), Others (Veterinary Telehealth, Veterinary Software, Livestock Monitoring)

Distribution Channel

Retail, E-Commerce, Hospital/Clinic Pharmacy

End Use

Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics and Others

Get your customized report @ https://www.skyquestt.com/speak-with-analyst/animal-health-market 

Following are the players analyzed in the report:

Zoetis Inc. 

Merck Animal Health 

Elanco Animal Health 

Boehringer Ingelheim Animal Health 

Bayer Animal Health 

Virbac 

Ceva Santé Animale 

IDEXX Laboratories, Inc. 

Vetoquinol S.A. 

Dechra Pharmaceuticals PLC 

Neogen Corporation 

Phibro Animal Health Corporation 

Kindred Biosciences, Inc. 

Norbrook Holdings Limited 

Heska Corporation 

Nutreco N.V. 

AniCura AB 

PetIQ, Inc. 

Idexx Laboratories 

Petmed Express, Inc.

Regional Analysis 1. North America: - The United States and Canada dominate the North American Animal Health Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Animal Health consumption. 2. Europe: - Europe is a significant player, with major Animal Health Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Animal Health manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Animal Health Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Animal Health Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

Buy your full report: https://www.skyquestt.com/buy-now/animal-health-market 

[tamanna31]

Health Check-up Market - The Biggest Trends to watch out for 2023-2030

Health Check-up Industry Overview

The global health check-up market size was valued at USD 48.71 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030.

The market growth is attributable to the increasing prevalence of chronic diseases, rising investments from government bodies to establish population medical screening initiatives, and the adoption of telemedicine & home-based services. For instance, in May 2023, the Indian Health Ministry launched a medical screening initiative for people with hypertension and diabetes. This initiative will provide standard care to around 75 million people suffering from non-communicable diseases by 2025.

Gather more insights about the market drivers, restrains and growth of the Health Check-up Market

Moreover, the introduction of telemedicine in general healthcare practices fueled the home-based testing market, while the healthcare ecosystem's digital connectivity framework powered the health check-up market during the COVID-19 pandemic. The increasing prevalence of life-threatening diseases is one of the key drivers for the industry. Additionally, non-communicable diseases such as diabetes, hypertension, cancer, and cardiovascular diseases are increasing, which often remain asymptomatic in the early stages. For instance, as per an AMGA article, more than 30% of the U.S. population suffers from prehypertension, increasing the chances of developing high blood pressure. Regular health check-up allows individuals to manage the condition effectively, as only 1 in 4 U.S. adults have their hypertension under control.

Additionally, government bodies are undertaking initiatives to screen the target population for different medical conditions. For instance, the U.S. Preventive Services Task Force (USPSTF) recommends yearly screening for adults aged 18 and older to manage blood pressure risks. Similarly, Middle Eastern economies have initiated medical screening programs to raise awareness of the increasing hypertension prevalence. For instance, in May 2023, the Ministry of Health and Prevention (MoHAP) UAE launched a national campaign for the early detection of hypertension. By 2030, UAE plans to reduce the prevalence of high blood pressure by 30%. Hence, increasing recommendations from government bodies will be key drivers for the global market.

The global market is experiencing innovation driven by the adoption of digital technology in the healthcare ecosystem. In the Europe region, countries are integrating medical services to improve healthcare facilities across multiple countries, which is driving the need for digital technologies. For instance, in June 2022, Nordic countries launched Nordic Interoperability Project (NIP) which aims to enable healthcare service providers in Sweden, Denmark, Norway, Finland, and Iceland to evaluate an integrated digital medical ecosystem focused on self-management and preventive care. Additionally, a proposal from the European Commission in May 2022 plans to create a European Health Data Space, which will harness the medical data of nearly 450 million people, thereby establishing cross-border digital healthcare connectivity. Increasing health monitoring through digital platforms will increase the adoption of general & preventive tests over the forecast period.

The availability of health insurance coverage that includes preventive care benefits encourages individuals to undergo routine check-ups, thereby driving market growth. For instance, as per the U.S. CDC, private health insurance in the U.S. covers around 66% of the insured population. In recent years, there has been a shift in insurance policies to prioritize preventive care. Most insurance providers now include preventive care services, such as health check-ups, vaccinations, and screenings, as part of their coverage at no additional cost. Furthermore, insurance companies require policyholders to undergo medical risk assessments as part of the underwriting process. These assessments typically involve health check-ups and help insurers assess the individual's wellness and determine appropriate coverage and premiums. Hence, underwriting processes and growing awareness of preventive care are anticipated to drive market growth

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• The global cancer biopsy market size was valued at USD 30.05 billion in 2023 and is projected to grow at a CAGR of 8.11% from 2024 to 2030.

• The global pediatric allergy diagnostics market size was estimated at USD 2.44 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024 to 2030.

Key Health Check-up Company Insights

The key players operating in the health check-up industry are enhancing healthcare services and increasing strategic initiatives such as collaboration between government and private companies to enhance the efficiency and effectiveness of medical screening services. Moreover, the increasing introduction of direct-to-customer tests is further anticipated to fuel the market growth over the forecast period. For instance, in February 2023, Hurdel launched a Vitamin D test in the U.S., which will be sold on the company’s online store. Furthermore, the preventive test will allow the physicians to discuss concerns over chronic conditions and wellness. Some prominent players in global health check-up market include:

Quest Diagnostics Incorporated

Laboratory Corporation of America Holdings

SYNLAB International GmbH

OPKO Health, Inc. (BioReference Health, LLC.)

Eurofins Scientific

UNILABS

Sonic Healthcare Limited

ARUP Laboratories

Q2 Solutions

LalPathLabs.com

Order a free sample PDF of the Health Check-up Market Intelligence Study, published by Grand View Research.

[prajwal-agale001]

Global Lipid Nutrition Market Growth Projected at $24.71 Billion by 2030, Led by North America

According to the latest analysis by Meticulous Research®, the global lipid nutrition market is projected to surge to $24.71 billion by 2030, growing at a robust CAGR of 8.9% from 2023 to 2030. The market's growth is primarily fueled by rising incidences of chronic diseases, an aging population, and a heightened demand for infant nutrition and dietary supplements. However, challenges such as the limited availability of fish oil and an unpredictable regulatory landscape are expected to moderately impede the market’s growth.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3045

Market Segmentation and Growth Drivers

The lipid nutrition market is categorized by type, source, form, application, and geography:

By Type:

The market is segmented into omega-3 (including EPA, DHA, and ALA), medium-chain triglycerides (MCTs), omega-6 (including ARA, GLA, CLA), long-chain triglycerides, omega-9, and others.

Notably, the omega-3 segment is projected to dominate the market in 2023 due to its health benefits, particularly in reducing the risk of heart disease and managing rheumatoid arthritis. Growing demand for omega-3 in animal feed is also anticipated to fuel this segment’s growth.

By Source:

Lipid nutrition products are sourced from both marine (fish oil, algae oil, krill oil) and plant-based sources (coconut oil, flaxseed oil, chia seed oil).

The plant-sourced lipids segment is expected to witness the highest growth during the forecast period, driven by rising health consciousness, increasing vegetarian populations, and readily available plant-based raw materials.

By Form:

The market is divided into liquid and dry forms, with the liquid segment forecast to hold the largest share in 2023. This is attributed to the liquid form’s popularity in soft gel capsule production, ease of consumption, and cost-effective processing.

By Application:

Key applications include dietary supplements, food & beverages, pharmaceuticals, and animal feed.

The dietary supplements segment is expected to dominate in 2023 due to rising consumer awareness about nutrition, the surge in product launches, and increasing demand for health supplements.

Regional Insights

Geographically, North America is set to lead the lipid nutrition market in 2023, driven by factors such as the presence of major nutritional lipid manufacturers, a growing vegan population, significant investments in research & development, and high disposable incomes.

Competitive Landscape

The global lipid nutrition market is moderately competitive, with a mix of global, regional, and local players. Leading companies include:

Koninklijke DSM N.V. (Netherlands)

Polaris Nutritional Lipids (France)

Archer Daniels Midland Company (U.S.)

BASF SE (Germany)

Cargill, Incorporated (U.S.)

Omega Protein Corporation (U.S.)

These companies are at the forefront of innovation and development within the lipid nutrition sector, striving to meet the growing consumer demand for health-focused lipid products.

Read Full Report:- https://www.meticulousresearch.com/product/lipid-nutrition-market-3045?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=13-09-2024

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Connect with us on Twitter- https://twitter.com/MeticulousR123

[credenceresearchdotblog]

The Erythropoietin (EPO) drug Market is poised for substantial growth, with its market size projected to expand from USD 11,728.5 million in 2024 to USD 24,205.87 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.48%.The global erythropoietin (EPO) drugs market has experienced significant growth in recent years, driven by an increasing prevalence of anemia, particularly among patients with chronic kidney disease (CKD), cancer, and HIV. Erythropoietin, a glycoprotein hormone produced by the kidneys, plays a crucial role in the production of red blood cells (erythropoiesis). The synthetic forms of erythropoietin, known as erythropoiesis-stimulating agents (ESAs), are commonly used to treat anemia by stimulating the bone marrow to produce more red blood cells.

Browse the full report at https://www.credenceresearch.com/report/erythropoietin-drugs-market

Market Dynamics

The erythropoietin drugs market is primarily driven by the rising incidence of chronic diseases such as CKD and cancer. Anemia is a common complication in these diseases, leading to a growing demand for EPO drugs. According to the World Health Organization (WHO), anemia affects approximately 1.62 billion people globally, with iron deficiency anemia being the most prevalent type. This high prevalence, coupled with the increasing number of patients undergoing dialysis, chemotherapy, and antiretroviral therapy, is fueling the demand for EPO drugs.

The market is further bolstered by the growing geriatric population, which is more susceptible to chronic diseases and anemia. Additionally, advancements in biotechnology have led to the development of newer, more effective EPO formulations, enhancing treatment outcomes and expanding the market.

Regional Analysis

The erythropoietin drugs market is geographically segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

- North America: This region dominates the global market due to the high prevalence of CKD, well-established healthcare infrastructure, and the presence of major pharmaceutical companies. The U.S. is the largest market within this region, driven by a high rate of dialysis procedures and an aging population. - Europe: The market in Europe is also significant, with countries like Germany, the UK, and France leading due to their advanced healthcare systems and the widespread adoption of biosimilars.

- Asia-Pacific: This region is expected to witness the highest growth rate during the forecast period, attributed to a large patient population, increasing healthcare spending, and growing awareness about anemia management.

- Latin America and the Middle East & Africa: These regions are gradually emerging as potential markets due to improving healthcare infrastructure and increasing access to medical treatments.

Challenges and Opportunities

Despite the positive growth outlook, the erythropoietin drugs market faces several challenges. The high cost of biologics, side effects associated with EPO drugs, and stringent regulatory requirements are some of the key barriers to market growth. Additionally, the emergence of biosimilars poses competition to established biologics, potentially leading to price wars and reduced profit margins for manufacturers.

However, the market also presents significant opportunities. The development of next-generation EPO drugs with improved efficacy and safety profiles, coupled with the expanding applications of these drugs beyond anemia, could drive future growth. Moreover, the increasing focus on personalized medicine and targeted therapies is expected to open new avenues in the erythropoietin drugs market.

Key Player Analysis:

Amgen Inc.

Johnson & Johnson

F. Hoffmann-La Roche Ltd.

Pfizer Inc.

Novartis AG

Biocon Limited

Teva Pharmaceutical Industries Ltd.

Dr. Reddy’s Laboratories Ltd.

LG Life Sciences Ltd.

Wockhardt Ltd.

Segmentation:

by Drug Type 

Biologics

Biosimilars

by Product Type

Epoetin-alfa

Epoetin-beta

Darbepoetin-alfa

Others

by Application

Haematology

Kidney Disorder

Cancer

Others

by End User

Hospitals

Homecare

Specialty Clinics

Others

Browse the full report at https://www.credenceresearch.com/report/erythropoietin-drugs-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[industrynewsupdates]

Enteral Feeding Devices Market Key Drivers and Emerging Trends 2024-2030

The global enteral feeding devices market size was valued at USD 4.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2030. 

Growing geriatric population has resulted in increased incidences of diabetes, severe pancreatitis, and other gastrointestinal diseases, which aids market growth. Adoption of the “Feed Early Enteral Diet Adequately for Maximum Effect” (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse balloon designs are also expected to aid in growth during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Enteral Feeding Devices Market

Numerous NCBI studies suggest that people over 65 years pose a higher risk of developing chronic illnesses including Parkinson’s and nervous system disorders. The global population aged 60 years and older is expected to increase from around 1 billion in 2020 to about 1.4 billion in 2030 and is expected to double by 2050 to reach around 2.1 billion. The number of elderly patients with critical illnesses has increased significantly over the past few years. The risk of malnutrition and frailty among the geriatric population with comorbidities, such as stroke, depression, and dementia, is much higher, mainly owing to various age-related changes in body composition and muscle mass. This results in a reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of falls or injuries.

Enteral Feeding Devices Market Segmentation

Grand View Research, Inc. has segmented the global enteral feeding devices market report based on product, age group, indication, end-use, and region:

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Giving Set

• Enteral Feeding Pump

• Percutaneous Endoscopic Gastrostomy Device

• Low Profile Gastrostomy Device

• Nasogastric Tube

• Gastrostomy Tube

Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Adults 

• Pediatrics

Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Alzheimer’s

• Nutrition Deficiency

• Cancer Care

• Diabetes

• Chronic Kidney Diseases

• Orphan Diseases

• Dysphagia

• Pain Management

• Malabsorption/GI Disorder/Diarrhea

• Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

o Cardiology

o Neurology

o Critical Care (ICU)

o Oncology

o Others

�� Home Care

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o France

o Spain `          

o Italy

o Russia

o Sweden

o Norway

o Denmark

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

o Singapore

• Latin America

o Brazil

o Mexico

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global surgical drills market size was estimated at USD 1.27 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030.

• The global ophthalmic ultrasound devices market size was valued at USD 590.9 million in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2030.

Key Companies & Market Share Insights

The market players are focusing on product development, new technological advancements, and other initiatives to strengthen their market position.

Key Enteral Feeding Devices Companies:

• Conmed Corporation

• C.R.Bard

• Cook Medical

• Boston Scientific Corporation

• Moog Inc.

• Fresenius Kabi AG

• Danone Medical Nutrition

• Kimberly-Clark

• Abbott Nutrition

• B Braun Melsungen AG

• Avanos Medical, Inc.

• Cardinal Health

• Applied Medical Technology, Inc.

• Vygon India

• Fidmi Medical

• ALCOR Scientific

• Amsino International, Inc.

Recent Developments

• In September 2023, Cardinal Health launched Kangaroo OMNI enteral feeding pump, intended to give patients undergoing enteral feeding more options to suit their individual needs over the course of their enteral feeding journey.

• In August 2023, Cardinal Health launched its next-generation NTrainerTM System 2.0, a medical device intended to shorten the length of stay in the neonatal intensive care unit (NICU) for premature and newborn infants by assisting them in developing the oral coordination skills necessary for the transition to independent feeding more quickly. The NTrainerTM System gives parents confidence in their newborns' progress and potential for success after discharge by giving clinicians the objective data they need to monitor an infant's development of pre-feeding skills through real-time assessment technology.

Order a free sample PDF of the Enteral Feeding Devices Market Intelligence Study, published by Grand View Research.

[foodandbeverages]

Fishmeal & Fish Oil Market Segmentation Application, Technology & Market Analysis Research Report To 2033

The fishmeal and fish oil market is anticipated to reach a value of US$ 7.4 billion in 2023 and US$ 13.0 billion in 2033. During the projection period, fishmeal and fish oil sales are anticipated to expand at a substantial CAGR of 5.8%.

The production of fishmeal and fish oil is expected to increase moderately in the coming years as a result of improved by-product utilization and a growing aquaculture industry.

According to the OECD, aquaculture's contribution to global fish culture will continue to grow and will surpass that of fisheries by 2024. Aquaculture production is expected to reach 105 million tons by 2029, ten million tons more than the capture sector.

As feed demand has increased in tandem with increased aquaculture production, the inclusion of fish meal and fish oil in feed recipes has clearly declined, and has been partially replaced by vegetable substitutes such as soymeal and rapeseed oil.

Due to their scarcity, fishmeal and fish oil will be employed more frequently as strategic ingredients at lower percentages and for particular production stages.

The development and dynamics of the markets for fish oil and fishmeal on a worldwide scale can be influenced by a variety of variables. Included in them are extrinsic variables like the weather and environment, fishery management, trade policies, etc.

Information Source: https://www.futuremarketinsights.com/reports/fishmeal-and-fish-oil-market

Key Takeaways from the Fishmeal & Fish Oil Market

The fishmeal and fish oil market were dominated by salmon and trout and is expected to grow at a CAGR of 5.6% by 2033. This is because salmon oil is high in the omega-3 fats DHA and EPA. Consuming omega-3 fatty acids from salmon oil has been linked to a number of health benefits.

Pharmaceutical sector will register a growth of 5.4% and lead the application segment. Pharmaceutical industry will be highly benefitted from the fish oil and fish feed market owing to growing trend of fish-based supplementation and high adoptability of fish by-products in medical sector.

The U.S. to contribute a whooping US$ 4.6 billion by 2033 in the global market. Favorable policies and the thriving marine industry are the key reason driving the market in the region.

The U.K. is witnessing a growth of 4.9% in the fish oil and fish feed market. The growing concern and awareness on animal nutrition and well being is the key factor behind this significant growth of the region.

China is the most lucrative region among all growing at an astonishing rate of 5.2%. China is the top consumer of fish and fish products among other regions. Growing awareness on cardiac issues is promoting the adoption of fish oil among population.

Asia Pacific is likely to be the dominant region for the market till the end of the forecast period.

Latest Developments

In April 2022, Evolve Supplements initiated its online store for aiding in the buying process for consumers.

In April 2022, Trident Seafoods came out with its Omega 3 food for dogs. They forayed into the pet food market with this initiative.

Key Segments Fish meal & Fish Oil Market

Source:

Salmon & Trout

Marine Fish

Crustaceans

Tilapia

Carps

Application:

Aquaculture & Aquatic Feeds

Land Animal Feeds and Livestock

Agriculture and Fertilizers

Pharmaceuticals

Dietary Supplements

By Region:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific excluding Japan (APEJ)

Japan

The Middle East & Africa (MEA)

[shubhampawrainfinium]

The Metabolic Revolution: New Therapeutic Approaches to Chronic Disorders

The global metabolic disorders therapeutics market is on a promising growth trajectory, fueled by the increasing prevalence of metabolic disorders and advancements in treatment options. Valued at over USD 70 billion in 2022, the market is projected to reach approximately USD 108 billion by 2028, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period from 2022 to 2028. This growth underscores the expanding focus on addressing metabolic disorders through innovative therapeutic solutions.

Why Metabolic Disorders Therapeutics?

Metabolic disorders encompass a range of conditions that affect the body's ability to convert food into energy effectively. These disorders include diabetes, obesity, hyperlipidemia, and inherited metabolic diseases. Therapeutics for these conditions aim to regulate metabolic processes, manage symptoms, and improve patients' quality of life. Advances in drug development and personalized medicine are transforming the treatment landscape for metabolic disorders, offering new hope for patients worldwide.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/145

Market Dynamics and Growth Drivers

Several factors are driving the growth of the global metabolic disorders therapeutics market:

Rising Prevalence: The increasing incidence of metabolic disorders, particularly type 2 diabetes and obesity, is driving demand for effective therapeutic solutions. Lifestyle changes, dietary habits, and genetic factors contribute to the growing prevalence of these conditions.

Advancements in Research and Development: Ongoing research and development efforts are leading to the discovery of novel drugs and treatment approaches for metabolic disorders. Innovations in drug formulation and targeted therapies are enhancing treatment outcomes and expanding therapeutic options.

Growing Awareness and Diagnosis: Increased awareness of metabolic disorders and advancements in diagnostic technologies are leading to earlier detection and diagnosis. Early intervention and personalized treatment plans contribute to improved patient outcomes and drive market growth.

Government Initiatives and Support: Governments and healthcare organizations are implementing initiatives to address the rising burden of metabolic disorders. Funding for research, public health campaigns, and supportive policies are fostering growth in the therapeutics market.

Regional Analysis

North America: North America remains a key market for metabolic disorders therapeutics, driven by high healthcare expenditure, advanced healthcare infrastructure, and a significant patient population. The U.S. and Canada are leading the market, with a focus on innovation and personalized medicine.

Europe: Europe is also experiencing substantial growth in the metabolic disorders therapeutics market, supported by increasing research investments and healthcare initiatives. Countries such as Germany, France, and the U.K. are prominent players in the market.

Asia-Pacific: The Asia-Pacific region is witnessing rapid growth in the market due to the rising prevalence of metabolic disorders, improving healthcare infrastructure, and increasing healthcare spending. Emerging economies like China and India are contributing significantly to market expansion.

Latin America and Middle East & Africa: These regions are experiencing gradual growth, with increasing healthcare access and awareness driving demand for metabolic disorders therapeutics. Market growth is supported by rising investments in healthcare infrastructure and drug development.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-metabolic-disorders-therapeutics-market

Competitive Landscape

The metabolic disorders therapeutics market is highly competitive, with several key players and emerging companies offering innovative treatments. Major companies in the market include:

Novo Nordisk: A global leader in diabetes care, Novo Nordisk offers a range of insulin and GLP-1 receptor agonists for diabetes management.

Sanofi: Sanofi provides a diverse portfolio of metabolic disorder therapeutics, including insulin and other diabetes management products.

Roche: Roche is known for its advancements in diabetes care and metabolic disorder treatments, with a focus on personalized medicine and innovative drug development.

Eli Lilly and Company: Eli Lilly offers a range of therapeutics for diabetes and other metabolic disorders, with a strong emphasis on research and innovation.

Challenges and Opportunities

The metabolic disorders therapeutics market faces challenges such as high treatment costs, side effects of existing therapies, and the need for personalized treatment approaches. Additionally, regulatory hurdles and market competition can impact the growth of new therapeutic options.

However, there are significant opportunities for growth. The increasing prevalence of metabolic disorders, advancements in research, and government support present avenues for innovation and investment. Companies that focus on developing effective, affordable, and personalized therapies are well-positioned to capitalize on the growing demand.

Conclusion

The global metabolic disorders therapeutics market is set for substantial growth, driven by rising prevalence, advancements in research, and increasing awareness. With revenue expected to reach approximately USD 108 billion by 2028, the market offers significant opportunities for innovation and investment. As the focus on metabolic health intensifies, therapeutics will play a crucial role in improving patient outcomes and managing metabolic disorders effectively.

[health-views-updates]

Medical Decision Support Systems for Sepsis Market Dynamics: Trends and Future Directions

The global market for medical decision support systems (MDSS) for sepsis is poised for unprecedented growth, with the market size expected to expand from USD 45.10 million in 2023 to a staggering USD 328.83 million by 2032. The compound annual growth rate (CAGR) of 24.70% over the forecast period from 2024 to 2032 reflects the growing need for advanced technologies to combat sepsis, a life-threatening condition.

Sepsis, a severe and potentially fatal response to infection, remains one of the leading causes of death in hospitals worldwide. Early detection and timely intervention are critical for improving patient outcomes. Medical decision support systems (MDSS) are advanced software solutions that leverage artificial intelligence (AI), machine learning, and big data analytics to assist healthcare professionals in diagnosing and treating sepsis more efficiently.

Key Market Drivers

Rising Incidence of Sepsis: Sepsis affects millions of people annually, with high mortality rates if not diagnosed and treated promptly. According to the World Health Organization (WHO), sepsis accounts for approximately 11 million deaths globally each year. The increasing incidence of sepsis, driven by aging populations, antimicrobial resistance, and rising chronic health conditions, is a significant factor driving the demand for MDSS. These systems provide real-time alerts and actionable insights, enabling clinicians to detect sepsis early and initiate timely treatment.

Advancements in AI and Machine Learning: The integration of AI and machine learning in healthcare has revolutionized the way diseases like sepsis are managed. AI-powered MDSS can analyze vast amounts of patient data, including vital signs, laboratory results, and medical history, to identify sepsis risk factors and predict patient outcomes. This predictive capability significantly enhances clinical decision-making and reduces the time it takes to diagnose and treat sepsis, leading to better patient outcomes and reduced mortality rates.

Improving Healthcare Efficiency: Medical decision support systems for sepsis not only improve patient care but also enhance operational efficiency within hospitals and healthcare systems. By automating data analysis and providing real-time recommendations, MDSS reduce the cognitive burden on healthcare providers, enabling them to make faster, more informed decisions. This is particularly crucial in intensive care units (ICUs), emergency departments, and other high-pressure environments where timely intervention is essential.

Government Initiatives and Hospital Adoption: Governments and healthcare organizations across the globe are increasingly prioritizing patient safety and clinical outcomes, which has spurred the adoption of MDSS. Regulatory bodies are pushing for better sepsis management protocols, and hospitals are investing in cutting-edge technologies to comply with these standards. For instance, the Centers for Medicare & Medicaid Services (CMS) in the U.S. has introduced sepsis quality measures that incentivize hospitals to adopt advanced decision support tools to improve sepsis detection and treatment.

Get a Free Sample Report: https://www.snsinsider.com/sample-request/2371 

Challenges and Opportunities

While the MDSS market for sepsis is expected to grow rapidly, several challenges remain. High implementation costs, the complexity of integrating MDSS with existing hospital infrastructure, and data privacy concerns may hinder market growth, especially in lower-income regions. However, the development of cloud-based and interoperable systems could alleviate some of these challenges by offering scalable, cost-effective solutions that can be seamlessly integrated into various healthcare settings.

Additionally, as healthcare systems worldwide continue to digitize, there is an opportunity for MDSS developers to create more user-friendly, adaptable platforms that can be tailored to different clinical environments. Innovations in wearable technology and remote monitoring devices also offer new possibilities for expanding the reach of MDSS for sepsis, enabling early detection outside of traditional hospital settings.

Regional Insights

North America currently dominates the medical decision support systems for sepsis market, largely due to its advanced healthcare infrastructure, high adoption of digital health technologies, and significant investment in AI and machine learning. The U.S., in particular, leads the market, driven by a focus on reducing sepsis-related mortality and improving healthcare quality standards.

Europe follows closely, with increasing investments in healthcare technology and government-led initiatives to improve sepsis care. The Asia-Pacific region is expected to witness the highest growth during the forecast period, driven by increasing healthcare expenditure, the growing burden of sepsis, and the rise of AI-driven innovations in countries such as China, Japan, and India.

Future Outlook

The future of medical decision support systems for sepsis looks promising, with significant advancements in AI, data analytics, and healthcare IT infrastructure expected to drive innovation in the sector. As the global healthcare industry continues to evolve, the adoption of MDSS for sepsis is expected to become a critical component of hospital systems, ultimately improving patient outcomes and saving lives.

By 2032, the market is expected to reach USD 328.83 million, representing a transformative shift in how sepsis is managed. With the ongoing development of predictive algorithms, real-time monitoring, and improved data integration, MDSS for sepsis will play a key role in shaping the future of healthcare

[ankitab]

The Continuous Glucose Monitoring Market is expected to reach $31.41 billion by 2031

Meticulous Research® has recently published a report forecasting the global continuous glucose monitoring (CGM) market to soar to $31.41 billion by 2031, growing at a robust compound annual growth rate (CAGR) of 15% between 2024 and 2031. This growth is largely fueled by several key factors, including the rising prevalence of diabetes, the increasing number of individuals leading sedentary lifestyles, and the clear advantages of continuous glucose monitoring systems over traditional glucose monitoring methods. Additionally, the adoption of CGM devices by athletes and fitness enthusiasts is contributing to market expansion. The report further highlights that advancements in CGM technology, the shift towards personalized healthcare, heightened health awareness, and improved access to diabetes care devices in low- and middle-income countries are expected to provide substantial growth opportunities.

Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5960?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

Leading Companies in the CGM Market

The report offers an in-depth analysis of the top players in the CGM market, examining their product portfolios, geographical presence, and strategic approaches over the past three to four years. The continuous glucose monitoring sector has seen a series of both organic and inorganic strategic developments in recent times. Notable companies profiled in the report include DexCom, Inc. (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (U.K.), LifeScan, Inc. (U.S.), Senseonics Holdings, Inc. (Maryland), A. Menarini Diagnostics S.r.l (Italy), Medtrum Technologies, Inc. (China), and B. Braun Melsungen SE (Germany).

Market Segmentation Insights

The continuous glucose monitoring market is segmented based on components (including Sensors [Disposable Sensors, Implantable Sensors], Transmitters, and Receivers), age group (Adults and Children), end-user (Home Care Settings and Hospitals & Clinics), and geography.

In 2024, the sensors segment is projected to command the largest portion of the market, with a share of 52.4%. This dominance is attributed to significant technological advancements in sensor technology, the availability of disposable sensors, and the increasing adoption of CGM systems over conventional glucometers. The high replacement rate of sensors compared to other components also plays a crucial role, as repeat purchases of sensors significantly contribute to the market’s growth.

Browse in depth:  https://www.meticulousresearch.com/product/continuous-glucose-monitoring-market-5960?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

When analyzing the market by age group, the adults segment is expected to hold the largest share of the CGM market in 2024. This can be traced to the high prevalence of diabetes among adults, the growing adoption of wearable devices, and an increasing focus on preventive healthcare. The adult population has a higher incidence of diabetes compared to children, which in turn drives greater demand for CGM devices within this age group.

In terms of end users, the home care settings segment is anticipated to account for the majority share of over 82.3% of the market by 2024. The rise in the elderly population and the growing burden of diabetes have amplified the need for self-monitoring and home care solutions. CGM systems designed for home use offer several benefits, including easier access, reduced travel time to healthcare facilities, enhanced awareness of diabetes management, and a broader shift towards preventive care.

Download request sample report here:https://www.meticulousresearch.com/request-sample-report/cp_id=5960?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

Regional Market Dynamics

Geographically, North America is projected to hold the largest share of the CGM market, accounting for over 42.2% in 2024. The region’s leading position can be attributed to factors such as a strong emphasis on patient engagement, a shift towards preventive healthcare, and widespread awareness and accessibility to CGM devices, particularly due to the availability of reimbursement options in developed countries. For example, a study by One Drop, a U.S.-based precision health solutions provider for diabetes and chronic conditions, found that approximately 2.4 million Americans were using CGM devices in 2022. This number is expected to grow significantly, further boosting the market share in North America.

Quick buy: https://www.meticulousresearch.com/Checkout/64947495?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

Key Questions Addressed in the Report:

What are the fastest-growing market segments by component, age group, end user, and geography?

How has the global market for continuous glucose monitoring evolved historically?

What are the market projections and estimates for the period 2024–2031?

What are the primary drivers, challenges, opportunities, and threats in the CGM market?

Who are the leading players in the continuous glucose monitoring market?

What is the competitive landscape of the market?

What recent developments have occurred in the CGM sector?

What strategies are major players employing in the continuous glucose monitoring market?

What are the regional trends and high-growth areas in the CGM market?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research